Department of Gynecology, Aalborg University Hospital, Aalborg, Denmark.
Public Health and Epidemiology Group, Aalborg University and Unit of Epidemiology and Biostatistics, Aalborg University Hospital, Aalborg, Denmark.
Int Urogynecol J. 2020 Sep;31(9):1813-1819. doi: 10.1007/s00192-020-04338-w. Epub 2020 May 24.
The primary objective of this study was to investigate the percentages of women choosing watchful waiting, pessary use or surgery as first-line treatment of pelvic organ prolapse (POP). Second, the rate and cause of discontinuation of pessary use were investigated.
A retrospective chart review was conducted on 794 patients referred with POP at a Danish tertiary center for urogynecology at Aalborg University Hospital between 1 January 2014 and 31 December 2015. The following data were registered: age, BMI, previous use of a pessary, total number of births, vaginal births, cesarean sections, previous hysterectomy, prolapse surgery and incontinence surgery, smoking, menopause, sexual status and POP-Q stage in the three vaginal compartments. Pessary treatments were evaluated after 3 months. Additional visits, reason for discontinuation and secondary treatment were noted.
First-line treatment was surgery in 50%, watchful waiting in 33% and pessary use in 17% of patients. Characteristics associated with choosing surgery instead of a pessary were age < 65 years, previous prolapse surgery, prolapse in the anterior or posterior compartment, and POP-Q stage > 2. Characteristics associated with choosing watchful waiting instead of a pessary were age < 65 years and prolapse in the posterior compartment. A total of 33% discontinued pessary treatment within the first 3 months. Discontinuation was associated with age < 65 years, previous hysterectomy and pelvic surgery, and additional visits. Expulsion of the pessary and pain/discomfort were the main causes of discontinuation.
This study showed that 50% of patients referred with POP were treated with conservative treatment (watchful waiting and pessary) and thus more women could probably be treated in primary care.
本研究的主要目的是调查选择观察等待、使用子宫托或手术作为盆腔器官脱垂(POP)一线治疗的女性比例。其次,还调查了子宫托使用的停用率和原因。
回顾性分析了 2014 年 1 月 1 日至 2015 年 12 月 31 日期间在丹麦奥尔堡大学医院妇产科转诊的 794 例 POP 患者的病历。登记了以下数据:年龄、BMI、以前使用子宫托的情况、总生育次数、阴道分娩次数、剖宫产次数、以前的子宫切除术、脱垂手术和尿失禁手术、吸烟、绝经、性生活状况和阴道三个部位的 POP-Q 分期。在 3 个月后评估子宫托治疗。记录了额外就诊、停用原因和二次治疗。
一线治疗是手术 50%、观察等待 33%和子宫托治疗 17%。选择手术而不是子宫托的特征是年龄<65 岁、以前有脱垂手术、前或后盆腔脱垂和 POP-Q 分期>2。选择观察等待而不是子宫托的特征是年龄<65 岁和后盆腔脱垂。总共有 33%的患者在最初 3 个月内停止了子宫托治疗。停用与年龄<65 岁、以前的子宫切除术和盆腔手术以及额外就诊有关。取出子宫托和疼痛/不适是停用的主要原因。
本研究表明,50%的 POP 转诊患者接受了保守治疗(观察等待和子宫托),因此更多的女性可能可以在初级保健中得到治疗。